Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Patients using these formulations should understand they are investigational and not equivalent to FDA-approved products
Knowing what causes them and how to respond helps you stay on track
A randomized, double-blind, placebo-controlled phase 2 study comparing the efficacy and safety of tirzepatide versus placebo in 196 patients with nonalcoholic steatohepatitis (SYNERGY-NASH) with or without diabetes is currently underway and is estimated to complete in 2024
Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats
US$ 27.91
US$ 24.77
US$ 21.44
US$ 27.16
